Kirino Sakura, Tamaki Nobuharu, Kurosaki Masayuki, Takahashi Yuka, Higuchi Mayu, Itakura Yoshie, Tanaka Yuki, Inada Kento, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Hayakawa Yuka, Kakegawa Tatsuya, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Okamoto Ryuichi, Izumi Namiki. Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population QUANTITATIVE IMAGING IN MEDICINE AND SURGERY. 2023.08; 13 (10): 6493-6502. ( PubMed, DOI )

Nobuhiko Ogasawara, Yoshihito Kano, Yosuke Yoneyama, Sakurako Kobayashi, Satoshi Watanabe, Sakura Kirino, Fausto D Velez-Bravo, Yourae Hong, Aleksandra Ostapiuk, Pavlo Lutsik, Iichiroh Onishi, Shinichi Yamauchi, Yui Hiraguri, Go Ito, Yusuke Kinugasa, Kenichi Ohashi, Mamoru Watanabe, Ryuichi Okamoto, Sabine Tejpar, Shiro Yui. Discovery of non-genomic drivers of YAP signaling modulating the cell plasticity in CRC tumor lines. iScience. 2024.03; 27 (3): 109247. ( PubMed, DOI )

Hayakawa Yuka, Tamaki Nobuharu, Nakanishi Hiroyuki, Kurosaki Masayuki, Tanaka Yuki, Inada Kento, Ishido Shun, Kirino Sakura, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Takahashi Yuka, Tsuchiya Kaoru, Okamoto Ryuichi, Izumi Namiki. 治療抵抗性肝性脳症に対するリファキシミン追加投与の効果(Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy) Internal Medicine. 2023.04; 62 (7): 973-978. ( ichushi )

Taisei Keitoku, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Shun Ishido, Michiko Yamada, Tsubasa Nobusawa, Hiroaki Matsumoto, Mayu Higuchi, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yasuhiro Asahina, Ryuichi Okamoto, Namiki Izumi. Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy. J Viral Hepat. 2023.04; 30 (4): 297-302. ( PubMed, DOI )

Satoshi Watanabe, Nobuhiko Ogasawara, Sakurako Kobayashi, Sakura Kirino, Masami Inoue, Yui Hiraguri, Sayaka Nagata, Hiromichi Shimizu, Go Ito, Tomohiro Mizutani, Yasuhiro Nemoto, Kiichiro Tsuchiya, Ryuichi Okamoto, Mamoru Watanabe, Shiro Yui. Organoids transplantation as a new modality to design epithelial signature to create a membrane-protective sulfomucin-enriched segment. J Gastroenterol. 2023.04; 58 (4): 379-393. ( PubMed, DOI )

Watanabe Satoshi, Ogasawara Nobuhiko, Kobayashi Sakurako, Kirino Sakura, Inoue Masami, Hiraguri Yui, Nagata Sayaka, Shimizu Hiromichi, Ito Go, Mizutani Tomohiro, Nemoto Yasuhiro, Tsuchiya Kiichiro, Okamoto Ryuichi, Watanabe Mamoru, Yui Shiro. 膜保護性スルホムチン濃縮セグメントを創製するための上皮シグネチャ設計のための新しいモダリティとしてのオルガノイド移植(Organoids transplantation as a new modality to design epithelial signature to create a membrane-protective sulfomucin-enriched segment) Journal of Gastroenterology. 2023.04; 58 (4): 379-393. ( ichushi )

Kirino Sakura, Tamaki Nobuharu, Kurosaki Masayuki, Kaneko Shun, Inada Kento, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Hayakawa Yuka, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Yasui Yutaka, Takahashi Yuka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Okamoto Ryuichi, Izumi Namiki. B型慢性肝炎患者におけるヌクレオチド/ヌクレオシドアナログ療法後の治療標的としてのアラニンアミノトランスフェラーゼ値(Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B) Hepatology Research. 2023.01; 53 (1): 35-42. ( ichushi )

Kobayashi Sakurako, Ogasawara Nobuhiko, Watanabe Satoshi, Yoneyama Yosuke, Kirino Sakura, Hiraguri Yui, Inoue Masami, Nagata Sayaka, Okamoto-Uchida Yoshimi, Kofuji Satoshi, Shimizu Hiromichi, Ito Go, Mizutani Tomohiro, Yamauchi Shinichi, Kinugasa Yusuke, Kano Yoshihito, Nemoto Yasuhiro, Watanabe Mamoru, Tsuchiya Kiichiro, Nishina Hiroshi, Okamoto Ryuichi, Yui Shiro. Collagen type I-mediated mechanotransduction controls epithelial cell fate conversion during intestinal inflammation(タイトル和訳中) Inflammation and Regeneration. 2022.11; 42 1 of 18-18 of 18. ( ichushi )

Yamashita K, Kurosaki M, Nakanishi H, Tanaka Y, Ishido S, Inada K, Kirino S, Hayakawa Y, Matsumoto H, Nobusawa T, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Tamaki N, Yasui Y, Tsuchiya K, Takahashi Y, Miyazaki R, Ashikaga T, Enomoto N, Izumi N. Simple algorithm to narrow down the candidates to receive echocardiography in patients with chronic liver disease for suspected pulmonary hypertension. JGH open : an open access journal of gastroenterology and hepatology. 2022.11; 6 (11): 774-781. ( PubMed, DOI )

Inada Kento, Tamaki Nobuharu, Kurosaki Masayuki, Kirino Sakura, Yamashita Koji, Hayakawa Yuka, Higuchi Mayu, Takaura Kenta, Kaneko Shun, Maeyashiki Chiaki, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Izumi Namiki. Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2022.09; 37 (9): 1726-1731. ( PubMed, DOI )

Hayakawa Y, Tamaki N, Nakanishi H, Kurosaki M, Tanaka Y, Inada K, Ishido S, Kirino S, Yamashita K, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Yasui Y, Takahashi Y, Tsuchiya K, Okamoto R, Izumi N. Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy. Internal medicine (Tokyo, Japan). 2022.09; 62 (7): 973-978. ( PubMed, DOI )

Kaneko S, Tsuchiya K, Yasui Y, Tanaka Y, Inada K, Ishido S, Kirino S, Yamashita K, Hayakawa Y, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Tamaki N, Takahashi Y, Nakanishi H, Irie T, Ariizumi SI, Kurosaki M, Izumi N. Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment. JGH open : an open access journal of gastroenterology and hepatology. 2022.05; 6 (5): 301-308. ( PubMed, DOI )

Hayakawa Yuka, Tsuchiya Kaoru, Kurosaki Masayuki, Yasui Yutaka, Kaneko Shun, Tanaka Yuki, Ishido Shun, Inada Kento, Kirino Sakura, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Asahina Yasuhiro, Okamoto Ryuichi, Izumi Namiki. Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice INVESTIGATIONAL NEW DRUGS. 2022.04; 40 (2): 392-402. ( PubMed, DOI )

Kaneko Shun, Kurosaki Masayuki, Tsuchiya Kaoru, Yasui Yutaka, Hayakawa Yuka, Inada Kento, Tanaka Yuki, Ishido Shun, Kirino Sakura, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Takahashi Yuka, Nakanishi Hiroyuki, Izumi Namiki. Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma PLOS ONE. 2022.03; 17 (3): e0265235. ( PubMed, DOI )

Sekiguchi S, Tsuchiya K, Yasui Y, Inada K, Kirino S, Yamashita K, Hayakawa Y, Osawa L, Higuchi M, Takaura K, Maeyashiki C, Kaneko S, Tamaki N, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Okamoto R, Kurosaki M, Izumi N. Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy. Cancer reports (Hoboken, N.J.). 2022.03; 5 (11): e1613. ( PubMed, DOI )

Tsuchiya Kaoru, Kurosaki Masayuki, Yasui Yutaka, Kaneko Shun, Kirino Sakura, Inada Kento, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Hayakawa Yuka, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Nakanishi Hiroyuki, Izumi Namiki. The therapeutic strategy for choosing lenvatinib in systemic therapy for unresectable hepatocellular carcinoma JOURNAL OF CLINICAL ONCOLOGY. 2022.02; 40 (4): ( DOI )

Takaura Kenta, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Yamashita Kouji, Muto Tomohiro, Osawa Leona, Sekiguchi Shuhei, Hayakawa Yuka, Higuchi Mayu, Kaneko Shun, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Itakura Jun, Tsuchiya Kaoru, Nakanishi Hiroyuki, Takahashi Yuka, Izumi Namiki. The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy PLOS ONE. 2022.02; 17 (2): e0264075. ( PubMed, DOI )

Higuchi Mayu, Tamaki Nobuharu, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Yamashita Koji, Hayakawa Yuka, Osawa Leona, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Takahashi Yuka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Loomba Rohit, Enomoto Nobuyuki, Izumi Namiki. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2022.02; 55 (3): 292-301. ( PubMed, DOI )

Osawa Leona, Nakanishi Hiroyuki, Kurosaki Masayuki, Kirino Sakura, Inada Kento, Yamashita Koji, Hayakawa Yuka, Sekiguchi Shuhei, Wang Wan, Okada Mao, Higuchi Mayu, Komiyama Yasuyuki, Takaura Kenta, Takada Hitomi, Kaneko Shun, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Tsuchiya Kaoru, Itakura Jun, Takahashi Yuka, Enomoto Nobuyuki, Izumi Namiki. Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by Tolvaptan DIGESTIVE DISEASES. 2022; 40 (4): 479-488. ( PubMed, DOI )

Tamaki Nobuharu, Kurosaki Masayuki, Kirino Sakura, Izumi Namiki. B型慢性肝炎患者における抗ウイルス療法中の肝細胞癌リスク予測モデルの診断精度(Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients) Hepatology Research. 2021.11; 51 (11): 1170-1171. ( ichushi )

Tamaki Nobuharu, Kurosaki Masayuki, Kirino Sakura, Izumi Namiki. Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients HEPATOLOGY RESEARCH. 2021.11; 51 (11): 1170-1171. ( PubMed, DOI )

Tamaki Nobuharu, Kurosaki Masayuki, Takahashi Yuka, Itakura Yoshie, Inada Kento, Kirino Sakura, Yamashita Koji, Sekiguchi Shuhei, Hayakawa Yuka, Osawa Leona, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Izumi Namiki. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2021.10; 36 (10): 2960-2966. ( PubMed, DOI )

Kaneko Shun, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Hayakawa Yuka, Yamashita Koji, Osawa Leona, Sekiguchi Shuhei, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Itakura Jun, Takahashi Yuka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Izumi Namiki. Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2021.10; 36 (10): 2943-2951. ( PubMed, DOI )

Tamaki Nobuharu, Higuchi Mayu, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Yamahita Koji, Sekiguchi Syuhei, Hayakawa Yuka, Oosawa Reona, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Takahashi Yuka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Loomba Rohit, Izumi Namiki. LONGITUDINAL ASSOCIATION BETWEEN MAGNETIC RESONANCE ELASTOGRAPHY AND LIVER-RELATED EVENTS AND CARDIOVASCULAR EVENTS IN NONALCOHOLIC FATTY LIVER DISEASE HEPATOLOGY. 2021.10; 74 8A.

Inada K, Kaneko S, Kurosaki M, Yamashita K, Kirino S, Osawa L, Hayakawa Y, Sekiguchi S, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Yasui Y, Itakura J, Takahashi Y, Tsuchiya K, Nakanishi H, Okamoto R, Izumi N. Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis. JGH open : an open access journal of gastroenterology and hepatology. 2021.09; 5 (9): 1085-1091. ( PubMed, DOI )

Kaneko Shun, Kurosaki Masayuki, Tsuchiya Kaoru, Yasui Yutaka, Inada Kento, Kirino Sakura, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Itakura Jun, Takahashi Yuka, Nakanishi Hiroyuki, Asano Daisuke, Irie Takumi, Kawachi Yasuyuki, Izumi Namiki. Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin grade HEPATOLOGY RESEARCH. 2021.08; 51 (8): 902-908. ( PubMed, DOI )

Kaneko Shun, Kurosaki Masayuki, Tsuchiya Kaoru, Yasui Yutaka, Inada Kento, Kirino Sakura, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Itakura Jun, Takahashi Yuka, Nakanishi Hiroyuki, Asano Daisuke, Irie Takumi, Kawachi Yasuyuki, Izumi Namiki. アルブミン-ビリルビングレードにより層別化した肝内胆管癌の予後(Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin grade) Hepatology Research. 2021.08; 51 (8): 902-908. ( ichushi )

Higuchi Mayu, Tamaki Nobuharu, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Yamashita Koji, Hayakawa Yuka, Sekiguchi Shuhei, Osawa Leona, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Enomoto Nobuyuki, Izumi Namiki. Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis C JOURNAL OF MEDICAL VIROLOGY. 2021.06; 93 (6): 3744-3751. ( PubMed, DOI )

Tamaki Nobuharu, Kurosaki Masayuki, Takahashi Yuka, Itakura Yoshie, Kirino Sakura, Inada Kento, Yamashita Koji, Sekiguchi Shuhei, Hayakawa Yuka, Osawa Leona, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Loomba Rohit, Izumi Namiki. Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021.01; 22 (1): ( PubMed, DOI )

Kaneko Shun, Tsuchiya Kaoru, Yasui Yutaka, Inada Kento, Kirino Sakura, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Takeguchi Takaya, Takeguchi Yuko, Nagano Takuya, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Himeno Yoshiro, Hoshi Akihiko, Kurosaki Masayuki, Izumi Namiki. 肝機能と門脈腫瘍血栓症に基づく進行肝細胞癌に対する戦略(Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis) Hepatology Research. 2020.12; 50 (12): 1375-1385. ( ichushi )

Kaneko Shun, Tsuchiya Kaoru, Yasui Yutaka, Inada Kento, Kirino Sakura, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Takeguchi Takaya, Takeguchi Yuko, Nagano Takuya, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Himeno Yoshiro, Hoshi Akihiko, Kurosaki Masayuki, Izumi Namiki. Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis HEPATOLOGY RESEARCH. 2020.12; 50 (12): 1375-1385. ( PubMed, DOI )

Kaneko S, Tsuchiya K, Yasui Y, Inada K, Kirino S, Yamashita K, Osawa L, Hayakawa Y, Sekiguchi S, Higuchi M, Takaura K, Maeyashiki C, Tamaki N, Takeguchi T, Takeguchi Y, Nakanishi H, Itakura J, Takahashi Y, Himeno Y, Kurosaki M, Izumi N. Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib. JGH open : an open access journal of gastroenterology and hepatology. 2020.12; 4 (6): 1183-1190. ( PubMed, DOI )

Osawa Leona, Nakanishi Hiroyuki, Kurosaki Masayuki, Kirino Sakura, Inada Kento, Yamashita Kouji, Hayakawa Yuka, Sekiguchi Shuhei, Higuchi Mayu, Komiyama Yasuyuki, Takaura Kenta, Takada Hitomi, Kaneko Shun, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Tsuchiya Kaoru, Itakura Jun, Takahashi Yuka, Enomoto Nobuyuki, Izumi Namiki. PLASMA RENIN ACTIVITY PREDICTS SURVIVAL AND LIVER-RELATED EVENTS IN LIVER CIRRHOSIS PATIENTS WITH ASCITES TREATED BY TOLVAPTAN. HEPATOLOGY. 2020.11; 72 1078.

Nakanishi Hiroyuki, Hayakawa Yuka, Kubota Youhei, Kurosaki Masayuki, Osawa Leona, Inada Kento, Kirino Sakura, Yamashita Koji, Sekiguchi Shuhei, Okada Mao, Wan Wang, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Tamaki Nobuharu, Yasui Yutaka, Noda Takamasa, Nakanishi Kaoru, Tsuchiya Kaoru, Itakura Jun, Takahashi Yuka, Izumi Namiki. Impaired brain function improved by l-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy SCIENTIFIC REPORTS. 2020.08; 10 (1): 13566. ( PubMed, DOI )

Tamaki Nobuharu, Kurosaki Masayuki, Higuchi Mayu, Kirino Sakura, Inada Kento, Yamashita Koji, Sekiguchi Shuhei, Hayakawa Yuka, Osawa Leona, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Izumi Namiki. 進行性線維症患者に対する内視鏡スクリーニング回避を目的としたアルブミン、ビリルビン、血小板基準の検証(Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis) Hepatology Research. 2020.08; 50 (8): 996-999. ( ichushi )

Tamaki Nobuharu, Kurosaki Masayuki, Nakanishi Hiroyuki, Itakura Jun, Inada Kento, Kirino Sakura, Yamashita Koji, Osawa Leona, Sekiguchi Shuhei, Hayakawa Yuka, Wang Wan, Okada Mao, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Takahashi Yuka, Izumi Namiki. Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B JOURNAL OF MEDICAL VIROLOGY. 2020.08; 92 (8): 1355-1358. ( PubMed, DOI )

Kaneko Shun, Kurosaki Masayuki, Joko Kouji, Marusawa Hiroyuki, Kondo Masahiko, Kojima Yuji, Uchida Yasushi, Kimura Hiroyuki, Tsuji Keiji, Yagisawa Hitoshi, Kusakabe Atsunori, Kobashi Haruhiko, Akahane Takehiro, Tamaki Nobuharu, Kirino Sakura, Abe Takehiko, Yoshida Hideo, Matsushita Tomomichi, Hasebe Chitomi, Izumi Namiki. Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score SCIENTIFIC REPORTS. 2020.08; 10 (1): 13021. ( PubMed, DOI )

Tamaki N, Kurosaki M, Higuchi M, Kirino S, Inada K, Yamashita K, Sekiguchi S, Hayakawa Y, Osawa L, Takaura K, Maeyashiki C, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Izumi N. Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis. Hepatology research : the official journal of the Japan Society of Hepatology. 2020.08; 50 (8): 996-999. ( PubMed, DOI )

Tamaki N, Kurosaki M, Kirino S, Yamashita K, Osawa L, Sekiguchi S, Hayakawa Y, Wang W, Okada M, Higuchi M, Takaura K, Maeyashiki C, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Enomoto N, Izumi N. Hepatitis B surface antigen reduction as a result of switching from long-term entecavir administration to tenofovir. JGH open : an open access journal of gastroenterology and hepatology. 2020.06; 4 (3): 429-432. ( PubMed, DOI )

Tsuchiya Kaoru, Kurosaki Masayuki, Kaneko Shun, Yasui Yutaka, Kirino Sakura, Sekiguchi Shuhei, Inada Kento, Yamashita Koji, Hayakawa Yuka, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Nakanishi Hiroyuki, Itakura Jun, Izumi Namiki. Predictive value of changes in plasma vascular endothelial growth factor at eight weeks after lenvatinib administration in patients with unresectable hepatocellular carcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2020.05; 38 (15):

Osawa Leona, Tamaki Nobuharu, Kurosaki Masayuki, Kirino Sakura, Watakabe Keiya, Wang Wan, Okada Mao, Shimizu Takao, Higuchi Mayu, Takaura Kenta, Takada Hitomi, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Enomoto Nobuyuki, Izumi Namiki. Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not alpha-Fetoprotein as a Long-Term Hepatocellular Carcinoma Predictor INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020.05; 21 (10): ( PubMed, DOI )

Okada Mao, Nakanishi Hiroyuki, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Yamashita Koji, Sekiguchi Shuhei, Hayakawa Yuka, Osawa Leona, Wang Wan, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Tamaki Nobuharu, Yasui Yutaka, Tsuchiya Kaoru, Itakura Jun, Takahashi Yuka, Izumi Namiki. The impact of skeletal muscle loss for hepatocellular carcinoma treated with lenvatinib JOURNAL OF CLINICAL ONCOLOGY. 2020.02; 38 (4):

Kaneko Shun, Tsuchiya Kaoru, Kurosaki Masayuki, Kirino Sakura, Inada Kento, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Watakabe Keiya, Okada Mao, Wang Wan, Shimizu Takao, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Takeguchi Takaya, Takeguchi Yuko, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Himeno Yoshiro, Izumi Namiki. レンバチニブ投与下の肝細胞癌患者の生存に関する画像効果判定の3基準(Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib) Hepatology Research. 2020.01; 50 (1): 137-143. ( ichushi )

Kaneko Shun, Tsuchiya Kaoru, Kurosaki Masayuki, Kirino Sakura, Inada Kento, Yamashita Koji, Osawa Leona, Hayakawa Yuka, Sekiguchi Shuhei, Watakabe Keiya, Okada Mao, Wang Wan, Shimizu Takao, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Takeguchi Takaya, Takeguchi Yuko, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Himeno Yoshiro, Izumi Namiki. Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib HEPATOLOGY RESEARCH. 2020.01; 50 (1): 137-143. ( PubMed, DOI )

Kaneko Shun, Kurosaki Masayuki, Tamaki Nobuharu, Itakura Jun, Hayashi Tsuguru, Kirino Sakura, Osawa Leona, Watakabe Keiya, Okada Mao, Wang Wan, Shimizu Takao, Higuchi Mayu, Takaura Kenta, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Takahashi Yuka, Watanabe Mamoru, Izumi Namiki. Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2019.11; 34 (11): 2004-2010. ( PubMed, DOI )

Wang Wan, Tsuchiya Kaoru, Kurosaki Masayuki, Yasui Yutaka, Inada Kento, Kirino Sakura, Yamashita Koji, Sekiguchi Shuhei, Hayakawa Yuka, Osawa Leona, Okada Mao, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Tamaki Nobuharu, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Asahina Yasuhiro, Enomoto Nobuyuki, Izumi Namiki. Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma-Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice CANCERS. 2019.10; 11 (10): ( PubMed, DOI )

Tamaki Nobuharu, Higuchi Mayu, Kurosaki Masayuki, Kirino Sakura, Osawa Leona, Watakabe Keiya, Wang Wan, Okada Mao, Shimizu Takao, Takaura Kenta, Takada Hitomi, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Enomoto Nobuyuki, Izumi Namiki. Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease SCIENTIFIC REPORTS. 2019.07; 9 (1): 10109. ( PubMed, DOI )

Tamaki N, Higuchi M, Kurosaki M, Kirino S, Osawa L, Watakabe K, Wang W, Okada M, Shimizu T, Takaura K, Takada H, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Enomoto N, Izumi N. Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals. Journal of viral hepatitis. 2019.07; 26 (7): 893-899. ( PubMed, DOI )

Inada Kento, Nakanishi Hiroyuki, Muto Tomohiro, Kirino Sakura, Yamashita Koji, Osawa Leona, Sekiguchi Shuhei, Hayakawa Yuka, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Itakura Jun, Takahashi Yuka, Tsuchiya Kaoru, Kurosaki Masayuki, Izumi Namiki. NBI併用拡大内視鏡検査で発見された早期胃癌の微小粘膜下浸潤の予測における拡張血管の臨床的有用性(Clinical usefulness of dilated vessels in early gastric cancer found by magnifying endoscopy with narrow-band imaging for predicting minute submucosal invasion). 日本消化器病学会雑誌 2021.10.01

Kaneko Shun, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Hayakawa Yuka, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Nakanishi Hiroyuki, Tsuchiya Kaoru, Izumi Namiki. HBe抗原陰性B型慢性肝炎患者における病勢進行のマーカーおよび肝細胞癌の予測リスク因子としてのB型肝炎コア関連抗原(Hepatitis B core-related antigen as a marker for disease progression and predictive risk of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients). 日本消化器病学会雑誌 2021.10.01

Kaneko Shun, Kurosaki Masayuki, Inada Kento, Kirino Sakura, Hayakawa Yuka, Tanaka Yuki, Ishido Shun, Yamashita Koji, Nobusawa Tsubasa, Matsumoto Hiroaki, Kakegawa Tatsuya, Higuchi Mayu, Takaura Kenta, Tanaka Shohei, Maeyashiki Chiaki, Tamaki Nobuharu, Yasui Yutaka, Nakanishi Hiroyuki, Tsuchiya Kaoru, Izumi Namiki. HBe抗原陰性B型慢性肝炎患者における疾患進行のマーカーおよび肝細胞癌の予測リスクとしてのB型肝炎コア関連抗原について(Hepatitis B core-related antigen as a marker for disease progression and predictive risk of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients). 肝臓 2021.09.01

SERUM WISTERIA FLORIBUNDA AGGLUTININ-POSITIVE MAC-2 BINDING PROTEIN AFTER ERADICATION OF HEPATITIS C VIRUS IS SUPERIOR TO ALPHA-FETOPROTEIN TO DEFINE PATIENTS AT HIGH AND LOW RISK OF HEPATOCELLULAR CARCINOMA DEVELOPMENT DURING THE LONG-TERM COURSEOsawa Leona, Tamaki Nobuharu, Kurosaki Masayuki, Kirino Sakura, Yamashita Kouji, Hayakawa Yuka, Sekiguchi Syuhei, Wang Wan, Okada Mao, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Izumi Namiki. SERUM WISTERIA FLORIBUNDA AGGLUTININ-POSITIVE MAC-2 BINDING PROTEIN AFTER ERADICATION OF HEPATITIS C VIRUS IS SUPERIOR TO ALPHA-FETOPROTEIN TO DEFINE PATIENTS AT HIGH AND LOW RISK OF HEPATOCELLULAR CARCINOMA DEVELOPMENT DURING THE LONG-TERM COURSE. Osawa Leona, Tamaki Nobuharu, Kurosaki Masayuki, Kirino Sakura, Yamashita Kouji, Hayakawa Yuka, Sekiguchi Syuhei, Wang Wan, Okada Mao, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Izumi Namiki. SERUM WISTERIA FLORIBUNDA AGGLUTININ-POSITIVE MAC-2 BINDING PROTEIN AFTER ERADICATION OF HEPATITIS C VIRUS IS SUPERIOR TO ALPHA-FETOPROTEIN TO DEFINE PATIENTS AT HIGH AND LOW RISK OF HEPATOCELLULAR CARCINOMA DEVELOPMENT DURING THE LONG-TERM COURSEOsawa Leona, Tamaki Nobuharu, Kurosaki Masayuki, Kirino Sakura, Yamashita Kouji, Hayakawa Yuka, Sekiguchi Syuhei, Wang Wan, Okada Mao, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Izumi Namiki. 2019.11 Boston

Tsuchiya Kaoru, Kurosaki Masayuki, Kaneko Shun, Wang Wan, Kirino Sakura, Tamaki Nobuharu, Yasui Yutaka, Nakanishi Hiroyuki, Itakura Jun, Izumi Namiki. CLINICAL OUTCOME OF TYROSINE KINASE INHIBITORS IN THE GERIATRIC PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA HEPATOLOGY.. 2019.11 Boston

Nakanishi Hiroyuki, Kurosaki Masayuki, Osawa Leona, Inada Kento, Yamashita Kouji, Kirino Sakura, Hayakawa Yuka, Sekiguchi Syuhei, Okada Mao, Wang Wan, Higuchi Mayu, Takaura Kenta, Maeyashiki Chiaki, Kaneko Shun, Tamaki Nobuharu, Tsuchiya Kaoru, Itakura Jun, Takahashi Yuka, Izumi Namiki. L-CARNITINE IMPROVES MINIMAL HEPATIC ENCEPHALOPATHY, REDUCES LIVER RELATED HOSPITALIZATION EVENTS AND CONTRIBUTES TO BETTER PROGNOSIS. 2019.11 Boston

Okada Mao, Nakanishi Hiroyuki, Kurosaki Masayuki, Kirino Sakura, Osawa Leona, Watakabe Keiya, Wang Wan, Shimizu Takao, Takaura Kenta, Takada Hitomi, Kaneko Shun, Tamaki Nobuharu, Yasui Yutaka, Tsuchiya Kaoru, Itakura Jun, Takahashi Yuka, Izumi Namiki. Myopenia as a significant prognostic factor in BCLC-B intermediate-stage hepatocellular carcinoma treated with sorafenib. 2019.06

Watakabe Keiya, Tamaki Nobuharu, Kirino Sakura, Osawa Leona, Wan Wang, Okada Mao, Shimizu Takao, Higuchi Mayu, Takaura Kenta, Kaneko Shun, Tsuchiya Kaoru, Nakanishi Hiroyuki, Itakura Jun, Kurosaki Masayuki, Izumi Namiki. Non-invasive prediction of gastroesophageal varies by serum wisteria floribunda agglutinin positiveMac-2 binding protein and FIB-4 index in chronic hepatitis C. 2019.05

Kaneko Shun, Kurosaki Masayuki, Tamaki Nobuharu, Itakura Jun, Kirino Sakura, Watakabe Keiya, Osawa Leona, Okada Mao, Wan Wang, Shimizu Takao, Higuchi Mayu, Takaura Kenta, Yasui Yutaka, Tsuchiya Kaoru, Nakanishi Hiroyuki, Takahashi Yuka, Izumi Namiki. Efficacy and safety of switching therapy from tenofovir disoproxil fumarate to tenofovir alafenamide for hepatitis B virus infection. 2019.05

Nanba Daisuke, Mohri Yasuaki, Okamoto Sakura, Matsumura Hiroyuki, Usami Takako, Aida Tomomi, Tanaka Koichi, Nishimura Emi K.. クローニングフリーCRISPR/Cas9技術によるDct遺伝子座を有するメラノサイト幹細胞の標的化(Targeting melanocyte stem cells with Dct locus by cloning-free CRISPR/Cas9 technology). 日本研究皮膚科学会年次学術大会・総会プログラム 2017.11.01